AACR Delivers Report on Disparities in Cancer Progress
By Elana Gotkine HealthDay Reporter
WEDNESDAY, May 15, 2024 -- In its biennial Cancer Disparities Progress Report published today, the American Association for Cancer Research presents the latest statistics on disparities in cancer progress experienced by ethnic-minority groups and other medically underserved populations in the United States.
Robert A. Winn, M.D., from the Virginia Commonwealth University Massey Comprehensive Cancer Center in Richmond, and colleagues note that Black and Indigenous individuals have the highest overall cancer death rates of all U.S. racial and ethnic groups, although their overall cancer incidence rates are lower than those of White individuals. Black men are more than twice as likely than White men to die from prostate cancer; Black women have a 40 percent higher likelihood of dying from breast cancer; and Black individuals are twice as likely to be diagnosed with and die from multiple myeloma. Compared with White individuals, American Indian or Alaska Native, Asian and Pacific Islander, and Hispanic individuals are more than twice as likely to die from stomach cancer; incidence and mortality rates for liver cancer are also higher among these groups.
The authors also report that among Asian women who have never smoked, lung cancer incidence is increasing. Residents of nonmetropolitan or rural counties are 38 percent more likely than those living in large metropolitan or urban areas to be diagnosed with and die from lung cancer. Notable disparities are also seen among sexual and gender minorities, including an increased risk for breast cancer among sexual-minority women and nearly double the likelihood of dying from prostate cancer for transgender women versus cisgender men.
"We have seen tremendous progress against cancer in the last few decades, but we must keep fighting to ensure equal access and improved health care delivery for all people," Winn said in a statement.
AACR Cancer Disparities Progress Report 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Vaginal Cancer Incidence Increasing Globally
WEDNESDAY, July 3, 2024 -- The incidence of vaginal cancer is increasing globally, according to a study published online June 25 in BJOG: An International Journal of Obstetrics...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.